Operating
Change in receivables
Eli Lilly Change in receivables remained flat by 0.0% to $1.75B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 224.8%, from $538.75M to $1.75B. Over 4 years (FY 2021 to FY 2025), Change in receivables shows an upward trend with a 53.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 12, 2026
How to read this metric
An increase represents a use of cash, while a decrease represents a source of cash from improved collections.
Detailed definition
This metric tracks the net change in accounts and other receivables during the reporting period, reflecting the differen...
Peer comparison
Highly dependent on industry payment cycles; energy companies often see fluctuations based on seasonal demand and contract terms.
Metric ID:
change_in_receivablesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.28B | $299.60M | $2.45B | $2.16B | $7.00B |
| YoY Change | — | -76.6% | +718.1% | -12.1% | +224.8% |
Range$299.60M – $7.00B
CAGR+53.0%
Avg YoY Growth+213.6%
Median YoY Growth+106.4%
Change in receivables at Other Companies
Frequently Asked Questions
- What is Eli Lilly's change in receivables?
- Eli Lilly (LLY) reported change in receivables of $1.75B in Q4 2025.
- How has Eli Lilly's change in receivables changed year-over-year?
- Eli Lilly's change in receivables increased by 224.8% year-over-year, from $538.75M to $1.75B.
- What is the long-term trend for Eli Lilly's change in receivables?
- Over 4 years (2021 to 2025), Eli Lilly's change in receivables has grown at a 53.0% compound annual growth rate (CAGR), from $1.28B to $7.00B.
- What does change in receivables mean?
- The net change in the amount of money owed to the company by customers and other parties.